In more advanced stages of AKI, the increased expression of TNF-α, a known activator of NFκB and p53, may lead to the persistence of the polyamine catabolic activity via the NFκB and p 53 mediated expression of SAT1 and further enhancement of polyamine catabolism. The gene discussed is NFKB1; the disease is acute kidney injury.